IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System

January 9, 2018

KalVista Pharmaceuticals Commences Two Clinical Trials

January 5, 2018

Millendo Acquires Alizé Pharma SAS to Expand Orphan Endocrinology Pipeline

December 20, 2017

GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer

December 14, 2017

Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS

November 28, 2017

KalVista Pharmaceuticals Announces Collaboration with Merck

November 14, 2017